

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 5.54418046 |
| 2 | central nervous system myelination (GO:0022010) | 5.54418046 |
| 3 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 5.33306119 |
| 4 | striated muscle contraction (GO:0006941) | 5.25828078 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.18412462 |
| 6 | regulation of relaxation of muscle (GO:1901077) | 5.09667334 |
| 7 | actin filament-based movement (GO:0030048) | 5.07144525 |
| 8 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.66112068 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.54746354 |
| 10 | myofibril assembly (GO:0030239) | 4.50024857 |
| 11 | response to muscle activity (GO:0014850) | 4.44529364 |
| 12 | neuronal action potential propagation (GO:0019227) | 4.23108265 |
| 13 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.17579522 |
| 14 | cardiac muscle contraction (GO:0060048) | 4.09448655 |
| 15 | positive regulation of myotube differentiation (GO:0010831) | 4.07930475 |
| 16 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.99272459 |
| 17 | locomotory exploration behavior (GO:0035641) | 3.97184016 |
| 18 | sarcomere organization (GO:0045214) | 3.92386929 |
| 19 | muscle contraction (GO:0006936) | 3.90374059 |
| 20 | synaptic vesicle exocytosis (GO:0016079) | 3.88856361 |
| 21 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.87658217 |
| 22 | ensheathment of neurons (GO:0007272) | 3.83615781 |
| 23 | axon ensheathment (GO:0008366) | 3.83615781 |
| 24 | myelination (GO:0042552) | 3.83163110 |
| 25 | skeletal muscle contraction (GO:0003009) | 3.76502433 |
| 26 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.73475080 |
| 27 | actin-myosin filament sliding (GO:0033275) | 3.64577276 |
| 28 | muscle filament sliding (GO:0030049) | 3.64577276 |
| 29 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.60713873 |
| 30 | muscle system process (GO:0003012) | 3.53350832 |
| 31 | glutamate secretion (GO:0014047) | 3.49041258 |
| 32 | regulation of actin filament-based movement (GO:1903115) | 3.47399250 |
| 33 | creatine metabolic process (GO:0006600) | 3.45931933 |
| 34 | cellular potassium ion homeostasis (GO:0030007) | 3.41347023 |
| 35 | cardiac myofibril assembly (GO:0055003) | 3.40844425 |
| 36 | regulation of synapse structural plasticity (GO:0051823) | 3.38885232 |
| 37 | skeletal muscle tissue development (GO:0007519) | 3.38605229 |
| 38 | L-amino acid import (GO:0043092) | 3.38449237 |
| 39 | glycogen catabolic process (GO:0005980) | 3.37740204 |
| 40 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.37632058 |
| 41 | positive regulation of synapse maturation (GO:0090129) | 3.35731656 |
| 42 | sodium ion export (GO:0071436) | 3.33206297 |
| 43 | muscle fiber development (GO:0048747) | 3.31686640 |
| 44 | layer formation in cerebral cortex (GO:0021819) | 3.29797766 |
| 45 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.29238790 |
| 46 | striated muscle adaptation (GO:0014888) | 3.27963981 |
| 47 | glycine transport (GO:0015816) | 3.27504357 |
| 48 | skeletal muscle adaptation (GO:0043501) | 3.27167554 |
| 49 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.25458659 |
| 50 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.22840827 |
| 51 | cardiac muscle hypertrophy (GO:0003300) | 3.21974317 |
| 52 | skeletal muscle fiber development (GO:0048741) | 3.18366628 |
| 53 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17484134 |
| 54 | neuromuscular synaptic transmission (GO:0007274) | 3.17197755 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 3.16745044 |
| 56 | plasma membrane repair (GO:0001778) | 3.16514052 |
| 57 | glucan catabolic process (GO:0009251) | 3.16004603 |
| 58 | protein localization to synapse (GO:0035418) | 3.14448675 |
| 59 | actomyosin structure organization (GO:0031032) | 3.13491760 |
| 60 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.12142189 |
| 61 | vocalization behavior (GO:0071625) | 3.12054920 |
| 62 | membrane tubulation (GO:0097320) | 3.10758428 |
| 63 | nerve growth factor signaling pathway (GO:0038180) | 3.10355579 |
| 64 | dendrite morphogenesis (GO:0048813) | 3.07360948 |
| 65 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.06278286 |
| 66 | adult walking behavior (GO:0007628) | 3.06189408 |
| 67 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.05825233 |
| 68 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.05122904 |
| 69 | striated muscle hypertrophy (GO:0014897) | 3.04317517 |
| 70 | potassium ion import (GO:0010107) | 3.03324640 |
| 71 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.03115620 |
| 72 | NADH metabolic process (GO:0006734) | 3.02015518 |
| 73 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 3.00943617 |
| 74 | regulation of ARF protein signal transduction (GO:0032012) | 3.00153863 |
| 75 | neuronal ion channel clustering (GO:0045161) | 2.99900570 |
| 76 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.99392050 |
| 77 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.99392050 |
| 78 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.97182797 |
| 79 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.95834234 |
| 80 | cellular polysaccharide catabolic process (GO:0044247) | 2.94726556 |
| 81 | regulation of ARF GTPase activity (GO:0032312) | 2.93661923 |
| 82 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.93009346 |
| 83 | negative regulation of inclusion body assembly (GO:0090084) | 2.93004644 |
| 84 | cerebellar granule cell differentiation (GO:0021707) | 2.90702663 |
| 85 | regulation of striated muscle contraction (GO:0006942) | 2.90145588 |
| 86 | muscle cell cellular homeostasis (GO:0046716) | 2.90086036 |
| 87 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.89889152 |
| 88 | muscle hypertrophy (GO:0014896) | 2.89180891 |
| 89 | dendritic spine morphogenesis (GO:0060997) | 2.88883146 |
| 90 | glycogen biosynthetic process (GO:0005978) | 2.87013658 |
| 91 | glucan biosynthetic process (GO:0009250) | 2.87013658 |
| 92 | actin-mediated cell contraction (GO:0070252) | 2.86994711 |
| 93 | neuromuscular process controlling balance (GO:0050885) | 2.86155451 |
| 94 | regulation of cell communication by electrical coupling (GO:0010649) | 2.85999613 |
| 95 | myelin maintenance (GO:0043217) | 2.85855971 |
| 96 | muscle cell fate commitment (GO:0042693) | 2.84060303 |
| 97 | skeletal muscle tissue regeneration (GO:0043403) | 2.83966208 |
| 98 | transmission of nerve impulse (GO:0019226) | 2.83753347 |
| 99 | exploration behavior (GO:0035640) | 2.82850872 |
| 100 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.82168518 |
| 101 | muscle hypertrophy in response to stress (GO:0003299) | 2.82168518 |
| 102 | cardiac muscle adaptation (GO:0014887) | 2.82168518 |
| 103 | neuron cell-cell adhesion (GO:0007158) | 2.82047137 |
| 104 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.81984042 |
| 105 | regulation of synapse maturation (GO:0090128) | 2.81955875 |
| 106 | myotube differentiation (GO:0014902) | 2.81932429 |
| 107 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81341960 |
| 108 | regulation of skeletal muscle contraction (GO:0014819) | 2.79818977 |
| 109 | establishment of mitochondrion localization (GO:0051654) | 2.79294956 |
| 110 | negative regulation of axonogenesis (GO:0050771) | 2.79242264 |
| 111 | neurotransmitter secretion (GO:0007269) | 2.77109842 |
| 112 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.76635315 |
| 113 | muscle organ development (GO:0007517) | 2.76570973 |
| 114 | presynaptic membrane organization (GO:0097090) | 2.76547671 |
| 115 | myoblast fusion (GO:0007520) | 2.76539240 |
| 116 | positive regulation of myoblast differentiation (GO:0045663) | 2.74983637 |
| 117 | protein localization to endosome (GO:0036010) | 2.74224308 |
| 118 | neuromuscular junction development (GO:0007528) | 2.74212350 |
| 119 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.73305762 |
| 120 | regulation of membrane repolarization (GO:0060306) | 2.72300112 |
| 121 | striated muscle atrophy (GO:0014891) | 2.71794720 |
| 122 | muscle structure development (GO:0061061) | 2.71786423 |
| 123 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.70875234 |
| 124 | muscle adaptation (GO:0043500) | 2.70403406 |
| 125 | synaptic vesicle endocytosis (GO:0048488) | 2.70072875 |
| 126 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.68092504 |
| 127 | long-term memory (GO:0007616) | 2.67992856 |
| 128 | membrane depolarization during action potential (GO:0086010) | 2.67710069 |
| 129 | negative regulation of muscle contraction (GO:0045932) | 2.67357378 |
| 130 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.65912260 |
| 131 | activation of protein kinase A activity (GO:0034199) | 2.65722357 |
| 132 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.64859210 |
| 133 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.64859210 |
| 134 | neuron recognition (GO:0008038) | 2.64813015 |
| 135 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.63837444 |
| 136 | myotube cell development (GO:0014904) | 2.63602566 |
| 137 | regulation of female receptivity (GO:0045924) | 2.62981529 |
| 138 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.62748894 |
| 139 | polysaccharide catabolic process (GO:0000272) | 2.62615532 |
| 140 | synaptic transmission, glutamatergic (GO:0035249) | 2.61837400 |
| 141 | glutamate receptor signaling pathway (GO:0007215) | 2.60045238 |
| 142 | positive regulation of membrane potential (GO:0045838) | 2.58913556 |
| 143 | response to inactivity (GO:0014854) | 2.57727300 |
| 144 | regulation of dendritic spine development (GO:0060998) | 2.57699745 |
| 145 | amino acid import (GO:0043090) | 2.57629408 |
| 146 | negative regulation of protein localization to cell surface (GO:2000009) | 2.56501330 |
| 147 | neuromuscular process controlling posture (GO:0050884) | 2.56443000 |
| 148 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.55848044 |
| 149 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.54846001 |
| 150 | vesicle transport along microtubule (GO:0047496) | 2.53581043 |
| 151 | cortical actin cytoskeleton organization (GO:0030866) | 2.53531197 |
| 152 | potassium ion homeostasis (GO:0055075) | 2.53150046 |
| 153 | oligodendrocyte differentiation (GO:0048709) | 2.52505028 |
| 154 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.51646251 |
| 155 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.51502862 |
| 156 | neuron-neuron synaptic transmission (GO:0007270) | 2.50929176 |
| 157 | gamma-aminobutyric acid transport (GO:0015812) | 2.50513996 |
| 158 | substantia nigra development (GO:0021762) | 2.48342908 |
| 159 | organelle transport along microtubule (GO:0072384) | 2.47890304 |
| 160 | regulation of Rap GTPase activity (GO:0032317) | 2.45740207 |
| 161 | negative regulation of neurotransmitter transport (GO:0051589) | 2.45518819 |
| 162 | regulation of postsynaptic membrane potential (GO:0060078) | 2.45498618 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.32171771 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.63257884 |
| 3 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.75377384 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.68595546 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.60256003 |
| 6 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.52474117 |
| 7 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49676683 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49676683 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.45884982 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.43542622 |
| 11 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.35831283 |
| 12 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.29623160 |
| 13 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.29177296 |
| 14 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.27894399 |
| 15 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.22967061 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15705013 |
| 17 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.13213190 |
| 18 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09231672 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.08685668 |
| 20 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.08464637 |
| 21 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.04340721 |
| 22 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.98362243 |
| 23 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.97863230 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.88939040 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.86113288 |
| 26 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79239391 |
| 27 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.74886017 |
| 28 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.73500222 |
| 29 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.72540351 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.67316070 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.65886424 |
| 32 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.61128655 |
| 33 | KDM2B_26808549_Chip-Seq_K562_Human | 1.60035044 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.58257339 |
| 35 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.56115123 |
| 36 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.52589714 |
| 37 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.49614285 |
| 38 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.47606003 |
| 39 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.47606003 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.45783317 |
| 41 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.44517697 |
| 42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.44481199 |
| 43 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.32773487 |
| 44 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.31966731 |
| 45 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.30885751 |
| 46 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30165763 |
| 47 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.27471825 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.27257330 |
| 49 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.27231963 |
| 50 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.27106781 |
| 51 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.25831071 |
| 52 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24457087 |
| 53 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.23540561 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.23276584 |
| 55 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.21629353 |
| 56 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21283961 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.20337710 |
| 58 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.19725319 |
| 59 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.19498878 |
| 60 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18708922 |
| 61 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.18470562 |
| 62 | * P68_20966046_ChIP-Seq_HELA_Human | 1.18294359 |
| 63 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.18148735 |
| 64 | SA1_27219007_Chip-Seq_Bcells_Human | 1.16673543 |
| 65 | * ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.15842594 |
| 66 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.15535251 |
| 67 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13596546 |
| 68 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.13075896 |
| 69 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.12616271 |
| 70 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.11651230 |
| 71 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10992908 |
| 72 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10143808 |
| 73 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09027638 |
| 74 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.08659188 |
| 75 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08611682 |
| 76 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.05401623 |
| 77 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.04773791 |
| 78 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.03866609 |
| 79 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.03805234 |
| 80 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03786997 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03104312 |
| 82 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.02787430 |
| 83 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.02223142 |
| 84 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.01286330 |
| 85 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.00098379 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.98581018 |
| 87 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.98181051 |
| 88 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97794313 |
| 89 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.97686941 |
| 90 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.97001635 |
| 91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96840594 |
| 92 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96750397 |
| 93 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.96491706 |
| 94 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.96433923 |
| 95 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96319607 |
| 96 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.96001602 |
| 97 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.95227628 |
| 98 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.94673020 |
| 99 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.94399264 |
| 100 | AR_19668381_ChIP-Seq_PC3_Human | 0.94211269 |
| 101 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.94187568 |
| 102 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93591886 |
| 103 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.92097740 |
| 104 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91733394 |
| 105 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.91362801 |
| 106 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.91020276 |
| 107 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.90700384 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 0.90642774 |
| 109 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.90268672 |
| 110 | * RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90115236 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.89330259 |
| 112 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.89303459 |
| 113 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.88863081 |
| 114 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.86491460 |
| 115 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86429741 |
| 116 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.86204563 |
| 117 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.86096893 |
| 118 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.86061238 |
| 119 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.85905989 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.84790164 |
| 121 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.84394550 |
| 122 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.84167662 |
| 123 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84140146 |
| 124 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83954867 |
| 125 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.83364002 |
| 126 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.83018299 |
| 127 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.81863679 |
| 128 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.80941108 |
| 129 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.80004525 |
| 130 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.79820990 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.79707537 |
| 132 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.79449807 |
| 133 | TP53_16413492_ChIP-PET_HCT116_Human | 0.79195072 |
| 134 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.78514347 |
| 135 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.78065036 |
| 136 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.77457153 |
| 137 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77284749 |
| 138 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.75887218 |
| 139 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.75862512 |
| 140 | * SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.75763772 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.18345540 |
| 2 | MP0004270_analgesia | 4.34585961 |
| 3 | MP0004145_abnormal_muscle_electrophysio | 3.92395809 |
| 4 | MP0003880_abnormal_central_pattern | 3.67696816 |
| 5 | MP0000751_myopathy | 3.16666672 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.09087870 |
| 7 | MP0000920_abnormal_myelination | 2.98814057 |
| 8 | MP0000749_muscle_degeneration | 2.96697344 |
| 9 | MP0000747_muscle_weakness | 2.96172778 |
| 10 | MP0002064_seizures | 2.63305497 |
| 11 | MP0005451_abnormal_body_composition | 2.38803999 |
| 12 | MP0009745_abnormal_behavioral_response | 2.37850313 |
| 13 | MP0002332_abnormal_exercise_endurance | 2.37078204 |
| 14 | MP0005423_abnormal_somatic_nervous | 2.34558003 |
| 15 | MP0002272_abnormal_nervous_system | 2.25302938 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.20624252 |
| 17 | MP0009046_muscle_twitch | 2.17513976 |
| 18 | MP0002063_abnormal_learning/memory/cond | 2.15968947 |
| 19 | MP0003329_amyloid_beta_deposits | 2.15583281 |
| 20 | MP0001486_abnormal_startle_reflex | 2.12012088 |
| 21 | MP0008569_lethality_at_weaning | 2.10857053 |
| 22 | MP0003690_abnormal_glial_cell | 1.95122811 |
| 23 | MP0000759_abnormal_skeletal_muscle | 1.85018240 |
| 24 | MP0000733_abnormal_muscle_development | 1.81233086 |
| 25 | MP0004084_abnormal_cardiac_muscle | 1.75528589 |
| 26 | MP0002106_abnormal_muscle_physiology | 1.74921462 |
| 27 | MP0004885_abnormal_endolymph | 1.74725386 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.74402735 |
| 29 | MP0000955_abnormal_spinal_cord | 1.68057163 |
| 30 | MP0003634_abnormal_glial_cell | 1.67593996 |
| 31 | MP0001440_abnormal_grooming_behavior | 1.66636070 |
| 32 | MP0001968_abnormal_touch/_nociception | 1.64076307 |
| 33 | MP0004142_abnormal_muscle_tone | 1.60386503 |
| 34 | MP0001299_abnormal_eye_distance/ | 1.54388131 |
| 35 | MP0000778_abnormal_nervous_system | 1.53054874 |
| 36 | MP0005369_muscle_phenotype | 1.52682363 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.51559596 |
| 38 | * MP0004087_abnormal_muscle_fiber | 1.50452933 |
| 39 | MP0003950_abnormal_plasma_membrane | 1.49910153 |
| 40 | MP0002269_muscular_atrophy | 1.46473391 |
| 41 | MP0004233_abnormal_muscle_weight | 1.46472320 |
| 42 | MP0004811_abnormal_neuron_physiology | 1.45224015 |
| 43 | MP0001970_abnormal_pain_threshold | 1.44999168 |
| 44 | MP0004036_abnormal_muscle_relaxation | 1.44681804 |
| 45 | MP0002882_abnormal_neuron_morphology | 1.42639389 |
| 46 | * MP0005330_cardiomyopathy | 1.39015859 |
| 47 | MP0002066_abnormal_motor_capabilities/c | 1.38805437 |
| 48 | MP0002972_abnormal_cardiac_muscle | 1.38510585 |
| 49 | MP0009780_abnormal_chondrocyte_physiolo | 1.37764746 |
| 50 | MP0002229_neurodegeneration | 1.36742475 |
| 51 | MP0003633_abnormal_nervous_system | 1.36442353 |
| 52 | MP0005623_abnormal_meninges_morphology | 1.35499497 |
| 53 | MP0002184_abnormal_innervation | 1.35151155 |
| 54 | MP0002733_abnormal_thermal_nociception | 1.32092405 |
| 55 | MP0002822_catalepsy | 1.31125445 |
| 56 | MP0000013_abnormal_adipose_tissue | 1.26678524 |
| 57 | MP0000750_abnormal_muscle_regeneration | 1.24640790 |
| 58 | MP0001905_abnormal_dopamine_level | 1.23432909 |
| 59 | MP0001501_abnormal_sleep_pattern | 1.21910268 |
| 60 | MP0004858_abnormal_nervous_system | 1.18899951 |
| 61 | MP0003075_altered_response_to | 1.18847901 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.18447236 |
| 63 | MP0003631_nervous_system_phenotype | 1.17656849 |
| 64 | MP0002736_abnormal_nociception_after | 1.16968307 |
| 65 | MP0005620_abnormal_muscle_contractility | 1.16168871 |
| 66 | MP0004742_abnormal_vestibular_system | 1.16147719 |
| 67 | MP0005551_abnormal_eye_electrophysiolog | 1.15780684 |
| 68 | MP0002971_abnormal_brown_adipose | 1.12910136 |
| 69 | MP0000604_amyloidosis | 1.12797683 |
| 70 | MP0005386_behavior/neurological_phenoty | 1.12574794 |
| 71 | MP0004924_abnormal_behavior | 1.12574794 |
| 72 | MP0004130_abnormal_muscle_cell | 1.11763342 |
| 73 | MP0002090_abnormal_vision | 1.10501622 |
| 74 | MP0001502_abnormal_circadian_rhythm | 1.07244321 |
| 75 | MP0003172_abnormal_lysosome_physiology | 1.06314685 |
| 76 | MP0005058_abnormal_lysosome_morphology | 1.06245502 |
| 77 | MP0002909_abnormal_adrenal_gland | 1.03634313 |
| 78 | MP0002108_abnormal_muscle_morphology | 1.03268670 |
| 79 | MP0003632_abnormal_nervous_system | 1.01432650 |
| 80 | MP0002735_abnormal_chemical_nociception | 1.01381947 |
| 81 | MP0002557_abnormal_social/conspecific_i | 1.00976321 |
| 82 | MP0001529_abnormal_vocalization | 0.98742203 |
| 83 | MP0004215_abnormal_myocardial_fiber | 0.98009545 |
| 84 | MP0005166_decreased_susceptibility_to | 0.96802147 |
| 85 | MP0005167_abnormal_blood-brain_barrier | 0.96472656 |
| 86 | MP0004510_myositis | 0.95136808 |
| 87 | MP0005666_abnormal_adipose_tissue | 0.93255120 |
| 88 | * MP0010630_abnormal_cardiac_muscle | 0.92001934 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.87940438 |
| 90 | MP0004134_abnormal_chest_morphology | 0.87678427 |
| 91 | MP0002152_abnormal_brain_morphology | 0.87154206 |
| 92 | MP0008874_decreased_physiological_sensi | 0.86298184 |
| 93 | MP0000003_abnormal_adipose_tissue | 0.85821564 |
| 94 | MP0001348_abnormal_lacrimal_gland | 0.84056035 |
| 95 | MP0003303_peritoneal_inflammation | 0.82607831 |
| 96 | MP0005535_abnormal_body_temperature | 0.81989507 |
| 97 | MP0006138_congestive_heart_failure | 0.80338871 |
| 98 | MP0003045_fibrosis | 0.80264141 |
| 99 | MP0005266_abnormal_metabolism | 0.78486459 |
| 100 | MP0006276_abnormal_autonomic_nervous | 0.78069389 |
| 101 | MP0005670_abnormal_white_adipose | 0.76960726 |
| 102 | MP0001544_abnormal_cardiovascular_syste | 0.76854509 |
| 103 | MP0005385_cardiovascular_system_phenoty | 0.76854509 |
| 104 | MP0003646_muscle_fatigue | 0.76360829 |
| 105 | MP0003879_abnormal_hair_cell | 0.75925453 |
| 106 | MP0005645_abnormal_hypothalamus_physiol | 0.75421406 |
| 107 | MP0008961_abnormal_basal_metabolism | 0.74940436 |
| 108 | MP0002127_abnormal_cardiovascular_syste | 0.74862617 |
| 109 | MP0002837_dystrophic_cardiac_calcinosis | 0.74130031 |
| 110 | MP0003137_abnormal_impulse_conducting | 0.73568111 |
| 111 | MP0005171_absent_coat_pigmentation | 0.68750564 |
| 112 | MP0001943_abnormal_respiration | 0.67319359 |
| 113 | MP0001346_abnormal_lacrimal_gland | 0.65999667 |
| 114 | MP0003828_pulmonary_edema | 0.65559711 |
| 115 | MP0003091_abnormal_cell_migration | 0.64943498 |
| 116 | MP0008438_abnormal_cutaneous_collagen | 0.64389129 |
| 117 | MP0003705_abnormal_hypodermis_morpholog | 0.60747097 |
| 118 | MP0001963_abnormal_hearing_physiology | 0.59749932 |
| 119 | MP0001986_abnormal_taste_sensitivity | 0.59657300 |
| 120 | * MP0002069_abnormal_eating/drinking_beha | 0.59319585 |
| 121 | MP0004484_altered_response_of | 0.59037288 |
| 122 | MP0001177_atelectasis | 0.58397511 |
| 123 | MP0008260_abnormal_autophagy | 0.58211370 |
| 124 | MP0004185_abnormal_adipocyte_glucose | 0.58186231 |
| 125 | MP0001485_abnormal_pinna_reflex | 0.56767487 |
| 126 | MP0005375_adipose_tissue_phenotype | 0.56576628 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.56365392 |
| 128 | MP0009840_abnormal_foam_cell | 0.53568735 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 6.36958539 |
| 2 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.34812076 |
| 3 | Nemaline bodies (HP:0003798) | 6.21049316 |
| 4 | Type 1 muscle fiber predominance (HP:0003803) | 4.98998015 |
| 5 | Distal arthrogryposis (HP:0005684) | 4.95331027 |
| 6 | Round ear (HP:0100830) | 4.81437172 |
| 7 | Fetal akinesia sequence (HP:0001989) | 4.70778216 |
| 8 | Exercise-induced myalgia (HP:0003738) | 4.25515609 |
| 9 | Myopathic facies (HP:0002058) | 4.07333836 |
| 10 | Myokymia (HP:0002411) | 3.97926269 |
| 11 | Akinesia (HP:0002304) | 3.91418458 |
| 12 | Rhabdomyolysis (HP:0003201) | 3.90479010 |
| 13 | Difficulty running (HP:0009046) | 3.86868942 |
| 14 | Myoglobinuria (HP:0002913) | 3.68329924 |
| 15 | Calcaneovalgus deformity (HP:0001848) | 3.61494026 |
| 16 | Supranuclear gaze palsy (HP:0000605) | 3.60955807 |
| 17 | Ulnar deviation of the wrist (HP:0003049) | 3.59494482 |
| 18 | Muscle fiber splitting (HP:0003555) | 3.48425520 |
| 19 | Distal lower limb muscle weakness (HP:0009053) | 3.44080748 |
| 20 | Increased connective tissue (HP:0009025) | 3.40921055 |
| 21 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.37444249 |
| 22 | Hyporeflexia of lower limbs (HP:0002600) | 3.35630192 |
| 23 | * Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.35468743 |
| 24 | Deformed tarsal bones (HP:0008119) | 3.34750910 |
| 25 | Ankle clonus (HP:0011448) | 3.30294687 |
| 26 | Subaortic stenosis (HP:0001682) | 3.28071172 |
| 27 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.28071172 |
| 28 | Neurofibrillary tangles (HP:0002185) | 3.27831772 |
| 29 | Exercise-induced muscle cramps (HP:0003710) | 3.25834234 |
| 30 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.20805101 |
| 31 | Focal motor seizures (HP:0011153) | 3.11561389 |
| 32 | Malignant hyperthermia (HP:0002047) | 3.11181079 |
| 33 | Increased variability in muscle fiber diameter (HP:0003557) | 3.02303737 |
| 34 | Rimmed vacuoles (HP:0003805) | 3.00628680 |
| 35 | Sudden death (HP:0001699) | 3.00252123 |
| 36 | Asymmetric septal hypertrophy (HP:0001670) | 2.99675543 |
| 37 | Calf muscle hypertrophy (HP:0008981) | 2.94842754 |
| 38 | Bundle branch block (HP:0011710) | 2.80827638 |
| 39 | Absent phalangeal crease (HP:0006109) | 2.79263478 |
| 40 | * EMG: myopathic abnormalities (HP:0003458) | 2.77028195 |
| 41 | Areflexia of lower limbs (HP:0002522) | 2.73051601 |
| 42 | Cerebral inclusion bodies (HP:0100314) | 2.71935917 |
| 43 | Spastic gait (HP:0002064) | 2.67751301 |
| 44 | Dysmetria (HP:0001310) | 2.60657237 |
| 45 | Focal seizures (HP:0007359) | 2.59670485 |
| 46 | Abnormality of the calf musculature (HP:0001430) | 2.58027117 |
| 47 | Frequent falls (HP:0002359) | 2.54913113 |
| 48 | Generalized muscle weakness (HP:0003324) | 2.52697959 |
| 49 | Mutism (HP:0002300) | 2.52472176 |
| 50 | Visual hallucinations (HP:0002367) | 2.51142035 |
| 51 | Action tremor (HP:0002345) | 2.47896290 |
| 52 | * Gowers sign (HP:0003391) | 2.46391444 |
| 53 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.45887096 |
| 54 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.45887096 |
| 55 | Onion bulb formation (HP:0003383) | 2.44023483 |
| 56 | Myotonia (HP:0002486) | 2.43623590 |
| 57 | Neck muscle weakness (HP:0000467) | 2.39530335 |
| 58 | Muscle stiffness (HP:0003552) | 2.37773014 |
| 59 | Urinary urgency (HP:0000012) | 2.37135945 |
| 60 | Lower limb amyotrophy (HP:0007210) | 2.36697694 |
| 61 | Popliteal pterygium (HP:0009756) | 2.35238433 |
| 62 | Peripheral hypomyelination (HP:0007182) | 2.35177022 |
| 63 | Intention tremor (HP:0002080) | 2.33730250 |
| 64 | Atonic seizures (HP:0010819) | 2.30181299 |
| 65 | Fatigable weakness (HP:0003473) | 2.29887502 |
| 66 | Abnormality of the neuromuscular junction (HP:0003398) | 2.29887502 |
| 67 | Difficulty climbing stairs (HP:0003551) | 2.29730120 |
| 68 | Abnormal finger flexion creases (HP:0006143) | 2.29004100 |
| 69 | Weak cry (HP:0001612) | 2.27918120 |
| 70 | Postural instability (HP:0002172) | 2.26582681 |
| 71 | Abnormality of the corticospinal tract (HP:0002492) | 2.26470173 |
| 72 | Slender build (HP:0001533) | 2.19279516 |
| 73 | Rapidly progressive (HP:0003678) | 2.17648949 |
| 74 | Lower limb muscle weakness (HP:0007340) | 2.16382480 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 2.11725155 |
| 76 | Achilles tendon contracture (HP:0001771) | 2.09109269 |
| 77 | Epileptic encephalopathy (HP:0200134) | 2.08635321 |
| 78 | Bulbar palsy (HP:0001283) | 2.07418305 |
| 79 | Aplasia of the musculature (HP:0100854) | 2.06605570 |
| 80 | Foot dorsiflexor weakness (HP:0009027) | 2.06564989 |
| 81 | Cerebral hypomyelination (HP:0006808) | 2.06468814 |
| 82 | Heart block (HP:0012722) | 2.03578416 |
| 83 | Hip contracture (HP:0003273) | 2.02999642 |
| 84 | Depression (HP:0000716) | 2.02468594 |
| 85 | Type 2 muscle fiber atrophy (HP:0003554) | 2.01767830 |
| 86 | Abnormal auditory evoked potentials (HP:0006958) | 2.01187048 |
| 87 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.00441436 |
| 88 | Abnormality of the calcaneus (HP:0008364) | 1.98592057 |
| 89 | Abnormal atrioventricular conduction (HP:0005150) | 1.96167169 |
| 90 | Abnormality of placental membranes (HP:0011409) | 1.95236790 |
| 91 | Amniotic constriction ring (HP:0009775) | 1.95236790 |
| 92 | Muscle fiber atrophy (HP:0100295) | 1.95035942 |
| 93 | Rigidity (HP:0002063) | 1.93626314 |
| 94 | Spinal rigidity (HP:0003306) | 1.93124446 |
| 95 | Limb-girdle muscle atrophy (HP:0003797) | 1.92188387 |
| 96 | Neuronal loss in central nervous system (HP:0002529) | 1.91759566 |
| 97 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.91728523 |
| 98 | Termporal pattern (HP:0011008) | 1.91176674 |
| 99 | Insidious onset (HP:0003587) | 1.91176674 |
| 100 | Metatarsus adductus (HP:0001840) | 1.89099203 |
| 101 | Easy fatigability (HP:0003388) | 1.88929927 |
| 102 | * Scapular winging (HP:0003691) | 1.88714564 |
| 103 | Obstructive sleep apnea (HP:0002870) | 1.88714216 |
| 104 | Abnormality of the foot musculature (HP:0001436) | 1.87648953 |
| 105 | Diplopia (HP:0000651) | 1.85845689 |
| 106 | Abnormality of binocular vision (HP:0011514) | 1.85845689 |
| 107 | Broad-based gait (HP:0002136) | 1.84713641 |
| 108 | Absence seizures (HP:0002121) | 1.79990169 |
| 109 | Impaired vibration sensation in the lower limbs (HP:0002166) | 1.79838270 |
| 110 | Scanning speech (HP:0002168) | 1.79532021 |
| 111 | Upper limb amyotrophy (HP:0009129) | 1.78800650 |
| 112 | Distal upper limb amyotrophy (HP:0007149) | 1.78800650 |
| 113 | Generalized tonic-clonic seizures (HP:0002069) | 1.78629250 |
| 114 | * Waddling gait (HP:0002515) | 1.78261043 |
| 115 | Dilated cardiomyopathy (HP:0001644) | 1.77705435 |
| 116 | EMG: neuropathic changes (HP:0003445) | 1.77662237 |
| 117 | Megalencephaly (HP:0001355) | 1.77051940 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 1.74993685 |
| 119 | Ulnar deviation of finger (HP:0009465) | 1.74882795 |
| 120 | Nonprogressive disorder (HP:0003680) | 1.74391037 |
| 121 | Arterial tortuosity (HP:0005116) | 1.73424742 |
| 122 | Dialeptic seizures (HP:0011146) | 1.72821362 |
| 123 | Dysdiadochokinesis (HP:0002075) | 1.72732565 |
| 124 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.72059548 |
| 125 | Ventricular tachycardia (HP:0004756) | 1.71573305 |
| 126 | Insomnia (HP:0100785) | 1.71495215 |
| 127 | Progressive cerebellar ataxia (HP:0002073) | 1.71019744 |
| 128 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.70974430 |
| 129 | Febrile seizures (HP:0002373) | 1.66830287 |
| 130 | Hyperkalemia (HP:0002153) | 1.65756402 |
| 131 | Stridor (HP:0010307) | 1.65140153 |
| 132 | Muscular dystrophy (HP:0003560) | 1.64244871 |
| 133 | Thin ribs (HP:0000883) | 1.63276291 |
| 134 | Lipoatrophy (HP:0100578) | 1.60638247 |
| 135 | * Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.59713215 |
| 136 | Progressive muscle weakness (HP:0003323) | 1.55287760 |
| 137 | Hemiplegia (HP:0002301) | 1.54810676 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 2.71157859 |
| 2 | PAK6 | 2.59830963 |
| 3 | PHKG1 | 2.35664629 |
| 4 | PHKG2 | 2.35664629 |
| 5 | OBSCN | 2.34293066 |
| 6 | EPHA4 | 2.23201637 |
| 7 | STK39 | 2.14310560 |
| 8 | NTRK3 | 2.13301321 |
| 9 | PRPF4B | 2.04028157 |
| 10 | LIMK1 | 1.96855306 |
| 11 | CDK19 | 1.96207599 |
| 12 | KSR2 | 1.90149209 |
| 13 | OXSR1 | 1.89610903 |
| 14 | MARK1 | 1.80319164 |
| 15 | NTRK1 | 1.77063524 |
| 16 | PKN1 | 1.75221938 |
| 17 | TTN | 1.65446276 |
| 18 | PRKD3 | 1.62032753 |
| 19 | ICK | 1.60491666 |
| 20 | EPHB1 | 1.59596249 |
| 21 | MINK1 | 1.55295674 |
| 22 | PIK3CG | 1.53512787 |
| 23 | TYRO3 | 1.50155323 |
| 24 | UHMK1 | 1.48213210 |
| 25 | MAP2K3 | 1.47481776 |
| 26 | CAMKK1 | 1.44409183 |
| 27 | MOS | 1.39231717 |
| 28 | ROCK2 | 1.36243394 |
| 29 | CDK5 | 1.35048569 |
| 30 | MAP3K13 | 1.34283421 |
| 31 | WNK1 | 1.31927409 |
| 32 | MAP3K11 | 1.30714453 |
| 33 | FES | 1.29985559 |
| 34 | CDK14 | 1.27037989 |
| 35 | CDK15 | 1.26325733 |
| 36 | MAP3K4 | 1.25171465 |
| 37 | TRIB3 | 1.23736329 |
| 38 | MAP3K7 | 1.23025373 |
| 39 | DMPK | 1.20840299 |
| 40 | CDK18 | 1.20516762 |
| 41 | PRKCH | 1.18739081 |
| 42 | CDK11A | 1.13361342 |
| 43 | NTRK2 | 1.11710253 |
| 44 | MUSK | 1.10994093 |
| 45 | MARK2 | 1.09205970 |
| 46 | SIK2 | 1.09082202 |
| 47 | CAMK1G | 1.05293178 |
| 48 | NME1 | 1.04449515 |
| 49 | ARAF | 1.03885620 |
| 50 | DAPK2 | 1.03525521 |
| 51 | CAMK2B | 1.01678445 |
| 52 | MAPK12 | 1.01140440 |
| 53 | CSNK1G2 | 1.00167392 |
| 54 | PINK1 | 0.95162938 |
| 55 | RIPK4 | 0.94090125 |
| 56 | PDPK1 | 0.92447931 |
| 57 | CLK1 | 0.91192755 |
| 58 | CAMK2G | 0.90550270 |
| 59 | SGK494 | 0.89316121 |
| 60 | SGK223 | 0.89316121 |
| 61 | STK11 | 0.89285147 |
| 62 | NEK6 | 0.89096899 |
| 63 | CSNK1A1L | 0.88592332 |
| 64 | CSNK1G3 | 0.88105492 |
| 65 | FGFR2 | 0.87457911 |
| 66 | MAPKAPK5 | 0.87224422 |
| 67 | ALK | 0.86751111 |
| 68 | MAP2K4 | 0.86345220 |
| 69 | KSR1 | 0.84954597 |
| 70 | TESK1 | 0.83017960 |
| 71 | PDK1 | 0.82256150 |
| 72 | FGR | 0.81236844 |
| 73 | LATS2 | 0.79062244 |
| 74 | CAMK2D | 0.78850180 |
| 75 | DYRK1B | 0.77540808 |
| 76 | PRKD1 | 0.76097332 |
| 77 | PNCK | 0.75865680 |
| 78 | MAPK7 | 0.75242856 |
| 79 | MAP4K1 | 0.74239320 |
| 80 | SCYL2 | 0.73296599 |
| 81 | DDR2 | 0.73017767 |
| 82 | PAK3 | 0.71783626 |
| 83 | CAMK4 | 0.71633865 |
| 84 | TAOK2 | 0.70950840 |
| 85 | CCNB1 | 0.70784383 |
| 86 | RET | 0.70710762 |
| 87 | FYN | 0.70707289 |
| 88 | SGK3 | 0.69523843 |
| 89 | TNIK | 0.69345566 |
| 90 | CAMK2A | 0.69263287 |
| 91 | DAPK3 | 0.66642986 |
| 92 | MAP2K6 | 0.65963624 |
| 93 | MAPK4 | 0.64561463 |
| 94 | TESK2 | 0.64558485 |
| 95 | EEF2K | 0.64253234 |
| 96 | CAMKK2 | 0.64063286 |
| 97 | MAPK13 | 0.63927869 |
| 98 | BMX | 0.61567221 |
| 99 | ZAP70 | 0.61528188 |
| 100 | KDR | 0.59983028 |
| 101 | MAPKAPK3 | 0.59358463 |
| 102 | ILK | 0.58439214 |
| 103 | BCR | 0.57733388 |
| 104 | PTK2B | 0.55988072 |
| 105 | RIPK1 | 0.54646377 |
| 106 | SGK2 | 0.54242104 |
| 107 | CAMK1 | 0.53178562 |
| 108 | TBK1 | 0.52795721 |
| 109 | CSF1R | 0.52439599 |
| 110 | TNK2 | 0.52070237 |
| 111 | TAOK1 | 0.50953362 |
| 112 | ROCK1 | 0.50666332 |
| 113 | MAP3K2 | 0.48099278 |
| 114 | SGK1 | 0.47738929 |
| 115 | MAPK11 | 0.47091850 |
| 116 | GRK5 | 0.46672126 |
| 117 | CSNK1G1 | 0.46535094 |
| 118 | MAPK10 | 0.46025674 |
| 119 | STK38 | 0.45854821 |
| 120 | ERN1 | 0.44721592 |
| 121 | RPS6KA3 | 0.44636941 |
| 122 | PRKG1 | 0.43577201 |
| 123 | MAP2K1 | 0.43536177 |
| 124 | HCK | 0.43414543 |
| 125 | MAP3K1 | 0.43132995 |
| 126 | PRKAA1 | 0.41781188 |
| 127 | AKT2 | 0.41695502 |
| 128 | SYK | 0.39827421 |
| 129 | CDC42BPA | 0.38192375 |
| 130 | JAK1 | 0.38111327 |
| 131 | PRKAA2 | 0.35586212 |
| 132 | JAK2 | 0.35585360 |
| 133 | BRAF | 0.34340065 |
| 134 | TRPM7 | 0.33114808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.37800684 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.16563721 |
| 3 | Olfactory transduction_Homo sapiens_hsa04740 | 2.10693186 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.02727286 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.91864211 |
| 6 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.90932562 |
| 7 | Morphine addiction_Homo sapiens_hsa05032 | 1.90003813 |
| 8 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.89188944 |
| 9 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.87612128 |
| 10 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.87199618 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.83574854 |
| 12 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.80132191 |
| 13 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.77915540 |
| 14 | Salivary secretion_Homo sapiens_hsa04970 | 1.71591436 |
| 15 | Long-term potentiation_Homo sapiens_hsa04720 | 1.70360065 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.70013446 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.69904847 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.63769364 |
| 19 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.56700458 |
| 20 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.54792267 |
| 21 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.54585481 |
| 22 | Axon guidance_Homo sapiens_hsa04360 | 1.51309651 |
| 23 | Long-term depression_Homo sapiens_hsa04730 | 1.44629806 |
| 24 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.43544052 |
| 25 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42726433 |
| 26 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.42613919 |
| 27 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.38013187 |
| 28 | Insulin secretion_Homo sapiens_hsa04911 | 1.36927104 |
| 29 | Circadian rhythm_Homo sapiens_hsa04710 | 1.35415455 |
| 30 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.34297739 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.33884514 |
| 32 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.31088299 |
| 33 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.30596034 |
| 34 | Cocaine addiction_Homo sapiens_hsa05030 | 1.29962121 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.29091090 |
| 36 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.28648063 |
| 37 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26046671 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.22603531 |
| 39 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.22057607 |
| 40 | Gap junction_Homo sapiens_hsa04540 | 1.21330396 |
| 41 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.19639877 |
| 42 | * Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.17301206 |
| 43 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.17241334 |
| 44 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.17044545 |
| 45 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.16334950 |
| 46 | * Endocytosis_Homo sapiens_hsa04144 | 1.15593787 |
| 47 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.13181640 |
| 48 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.12300178 |
| 49 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.12259814 |
| 50 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.08998109 |
| 51 | Glioma_Homo sapiens_hsa05214 | 1.07949428 |
| 52 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06740034 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06058331 |
| 54 | MAPK signaling pathway_Homo sapiens_hsa04010 | 1.03924417 |
| 55 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.02942140 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 1.02751171 |
| 57 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.00863100 |
| 58 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.00381843 |
| 59 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.99922459 |
| 60 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.97065623 |
| 61 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.96205554 |
| 62 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.93286520 |
| 63 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91125345 |
| 64 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.88892899 |
| 65 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.88609735 |
| 66 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.86650343 |
| 67 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.85367375 |
| 68 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.85313281 |
| 69 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.84890721 |
| 70 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.84434120 |
| 71 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.82822088 |
| 72 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.82754391 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 0.82603486 |
| 74 | Tight junction_Homo sapiens_hsa04530 | 0.81854169 |
| 75 | Viral myocarditis_Homo sapiens_hsa05416 | 0.80505506 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.80094121 |
| 77 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.80061171 |
| 78 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.79824207 |
| 79 | Lysosome_Homo sapiens_hsa04142 | 0.79340689 |
| 80 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.78332662 |
| 81 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.77982675 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.76422708 |
| 83 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.73803970 |
| 84 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.73302790 |
| 85 | Taste transduction_Homo sapiens_hsa04742 | 0.72656066 |
| 86 | Prion diseases_Homo sapiens_hsa05020 | 0.71790864 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.71536326 |
| 88 | Melanogenesis_Homo sapiens_hsa04916 | 0.71161827 |
| 89 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.69874890 |
| 90 | Platelet activation_Homo sapiens_hsa04611 | 0.69567615 |
| 91 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.69330278 |
| 92 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.67418834 |
| 93 | Focal adhesion_Homo sapiens_hsa04510 | 0.66531941 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.65617635 |
| 95 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.64463652 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.62201081 |
| 97 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.62071183 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.61001633 |
| 99 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.60346705 |
| 100 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59478473 |
| 101 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58048670 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.56685033 |
| 103 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56367315 |
| 104 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.55053432 |
| 105 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54940890 |
| 106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54477513 |
| 107 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.53975283 |
| 108 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.53915786 |
| 109 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53771995 |
| 110 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.53287531 |
| 111 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52460501 |
| 112 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52403558 |
| 113 | Bile secretion_Homo sapiens_hsa04976 | 0.52267241 |
| 114 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.51777947 |
| 115 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51415545 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47675611 |
| 117 | Shigellosis_Homo sapiens_hsa05131 | 0.47142800 |
| 118 | Histidine metabolism_Homo sapiens_hsa00340 | 0.46728119 |
| 119 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45065151 |
| 120 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.44387921 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.42795507 |
| 122 | Tuberculosis_Homo sapiens_hsa05152 | 0.42408635 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.40977960 |
| 124 | Phagosome_Homo sapiens_hsa04145 | 0.40618083 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39075951 |
| 126 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.37677570 |

